LGD-3303 SARM – 20MG/ML – 60ML BOTTLE
$179.99
{{option.name}}:
{{selected_options[option.position]}}
{{value_obj.value}}
The company Ligand Pharmaceuticals originally developed the parent compound, LGD 4033. In 2007 they synthesized the derivative, 9-Chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3h-pyrrolo(3,2-f)quinolin-7(6h)-one, more commonly referred to as LGD-3303. This SARM for sale is an orally-available, non-steroidal compound that initial animal models of experimentation have found to increase bone mineral density (BMD) and muscle mass. Due to its excellent bioavailability and reported effectiveness, LGD-3303 is currently being studied for its ability to prevent cases of muscle wasting and osteoporosis.
Show More
Show Less